{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:30:16Z","timestamp":1789954216161,"version":"4.0.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.contraception.2009.07.004","type":"journal-article","created":{"date-parts":[[2009,8,24]],"date-time":"2009-08-24T08:08:35Z","timestamp":1251101315000},"page":"16-21","source":"Crossref","is-referenced-by-count":55,"title":["Postmarketing study of ORTHO EVRA\u00ae and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism"],"prefix":"10.1016","volume":"81","author":[{"given":"Susan S.","family":"Jick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina W.","family":"Hagberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohini K.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2009.07.004_bib1","first-page":"525","article-title":"Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice","volume":"48","author":"Henzl","year":"2003","journal-title":"J Reprod Med"},{"key":"10.1016\/j.contraception.2009.07.004_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00024677-200302030-00005","article-title":"Transdermal ethinylestradiol\/norelgestromin: a review of its use in hormonal contraception","volume":"2","author":"Goa","year":"2003","journal-title":"Treat Endocrinol"},{"key":"10.1016\/j.contraception.2009.07.004_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2006.01.001","article-title":"Risk of non-fatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 mcg of ethinyl estradiol","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.004_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2007.03.003","article-title":"Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 \u03bcg of ethinyl estradiol","volume":"76","author":"Jick","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.004_bib5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.contraception.2006.05.071","article-title":"Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch","volume":"74","author":"Jick","year":"2006","journal-title":"Contraception."},{"key":"10.1016\/j.contraception.2009.07.004_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.AOG.0000250968.82370.04","article-title":"Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users","volume":"109","author":"Cole","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2009.07.004_bib7","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2009.07.004_bib8","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/bmj.321.7270.1190","article-title":"Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis","volume":"321","author":"Jick","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2009.07.004_bib9","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2009.07.004_bib10","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2009.07.004_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(96)07496-X","article-title":"Population-based study of risk of venous thromboembolism associated with various oral contraceptives","volume":"349","author":"Farmer","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2009.07.004_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0010-7824(98)00033-X","article-title":"Oral contraceptive and venous thromboembolism. a case-control study","volume":"57","author":"Lidegaard","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.004_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/AOG.0b013e31818fdde4","article-title":"Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer","volume":"113","author":"Jick","year":"2009","journal-title":"Obstet Gynecol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782409003497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782409003497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T17:50:04Z","timestamp":1545069004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782409003497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0010782409003497"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2009.07.004","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}